Compare ALRS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALRS | LXRX |
|---|---|---|
| Founded | 1879 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 715.4M | 703.3M |
| IPO Year | 2019 | 2000 |
| Metric | ALRS | LXRX |
|---|---|---|
| Price | $29.39 | $1.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $25.40 | $4.15 |
| AVG Volume (30 Days) | 155.1K | ★ 2.8M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ 0.89 | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | $38.42 | N/A |
| Revenue Next Year | $4.68 | N/A |
| P/E Ratio | $32.70 | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $20.26 | $0.64 |
| 52 Week High | $29.33 | $2.53 |
| Indicator | ALRS | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.00 | 45.26 |
| Support Level | $23.13 | $1.52 |
| Resistance Level | N/A | $1.95 |
| Average True Range (ATR) | 0.67 | 0.13 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 90.74 | 19.39 |
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.